Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Oncogenomics
  • Published:

Allelic loss on chromosome 13q14 and mutation in deleted in cancer 1 gene in esophageal squamous cell carcinoma

Abstract

Previous studies have shown frequent allelic loss on chromosome 13 in esophageal squamous cell carcinoma (ESCC). We assessed the frequency of allelic loss on chromosome 13q14 and mutations of deleted in cancer 1 (DICE1) (also found on 13q14) in ESCC patients to determine if this candidate tumor suppressor gene has a role in the development of ESCC, and whether this gene was an inactivation target for allelic loss on chromosome 13q14. Initially, we examined allelic loss at five markers flanking DICE1 in 56 ESCC patients from Shanxi Province, China, and then examined the entire coding sequence of this gene for mutations using polymerase chain reaction–single-strand confirmation polymorphism (PCR–SSCP) analysis and DNA sequencing. Subsequently, we extended our evaluation to an additional 80 ESCC patients and 232 healthy individuals to confirm the germline variant found in the initial 56 ESCC patients. The frequencies of allelic loss were 71, 58, and 75% for D13S325, D13S757, and D13S887, respectively, in the initial 56 ESCC patients studied. Overall, 73% of informative patients had loss of heterozygosity (LOH) for at least one of these three markers. Somatic mutations were identified in three patients (3/56, 5%), and one novel polymorphism was identified in 3% of ESCC patients (4/136) and 3% of healthy individuals (6/232). We conclude that DICE1 mutations occur in ESCC but are infrequent. The candidate tumor suppressor gene corresponding to the frequent allelic loss on chromosome 13q14 in ESCC remains unknown.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

Abbreviations

ESCC:

esophageal squamous cell carcinoma

SSCP:

single-strand confirmation polymorphism

PCR:

polymerase chain reaction

LOH:

loss of heterozygosity

References

  • Boynton RF, Huang Y, Blount PL, Reid BJ, Raskind WH, Haggitt RC, Newkirk C, Resau JH, Yin J, McDaniel T and Meltzer SJ. (1991). Cancer Res., 51, 5766–5769.

  • Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, Weiss RA and Liotta LA. (1996). Laser capture microdissection. Science, 274, 998–1001.

    Article  CAS  Google Scholar 

  • Eìrìksdottir G, Johannesdottir G, Ingvarsson S, Bjornsdottir IB, Jonasson JG, Agnarsson BA, Hallgrimsson J, Gudmundsson J, Egilsson V, Sigurdsson H and Barkardottir RB. (1998). Eur. J. Cancer, 34, 2076–2081.

  • Hu N, Dawsey SM, Wu M, Bonney GE, He LJ, Han XY, Fu M and Taylor PR. (1992). Int. J. Epidemol., 21, 877–881.

  • Hu N, Huang J, Emmert-Buck MR, Tang ZZ, Roth MJ, Wang CY, Dawsey SM, Li G, Li WJ, Wang QH, Han XY, Ding T, Giffen C, Goldstein AM and Taylor PR. (2001). Clin. Cancer Res., 7, 883–891.

  • Hu N, Li G, Li WJ, Wang CY, Goldstein AM, Tang ZZ, Roth MJ, Dawsey SM, Huang J, Wang QH, Ding T, Giffen C, Taylor PR and Emmert-Buck MR. (2002). Clin. Cancer Res., 8, 1121–1126.

  • Hu N, Roth MJ, Emmert-Buck MR, Tang ZZ, Polymeropolous M, Wang QH, Goldstein AM, Han XY, Dawsey SM, Ding T, Giffen C and Taylor PR. (1999). Clin. Cancer Res., 5, 3476–3482.

  • Hu N, Roth MJ, Polymeropolous M, Tang ZZ, Emmert-Buck MR, Wang QH, Goldstein AM, Feng SS, Dawsey SM, Ding T, Zhuang ZP, Han XY, Reid T, Giffen C and Taylor PR. (2000). Genes Chromosomes Cancer, 27, 217–228.

  • Huang Y, Boynton RF, Blount PL, Silberstein RJ, Yin J, Tong Y, McDaniel TK, Newkirk C, Resau JH, Sridhara R, Reid BJ and Meltzer SJ. (1992). Cancer Res., 52, 6525–6530.

  • Huang J, Hu N, Goldstein AM, Emmert-Buck MR, Tang ZZ, Roth MJ, Wang QH, Dawsey SM, Han XY, Ding T, Li G, Giffen C and Taylor PR. (2000). Carcinogenesis, 21, 2019–2026.

  • Hyytinen ER, Frierson JR HF, Boyd JC, Chung LWK and Dong JT. (1999). Genes Chromosomes Cancer, 25, 108–114.

  • Kuroki T, Fujiwara Y, Nakamori S, Imaoka S, Kanematsu T and Nakamura Y. (1995). Br. J. Cancer, 72, 383–385.

  • Lee WH, Bookstein R, Hong F, Young LJ, Shew EY and Lee EY. (1987). Science, 235, 1394–1399.

  • Li G, Hu N, Goldstein AM, Tang ZZ, Roth MJ, Wang QH, Dawsey SM, Han XY, Ding T, Huang J, Giffen C, Taylor PR and Emmert-Buck MR. (2001). Genes Chromosomes & Cancer, 31, 390–397.

  • MacGee TL, Yandell DW and Dryjia TP. (1989). Gene, 80, 119–128.

  • Maesawa C, Tamura G, Suzuki Y, Ogasawara S, Ishida K, Satio K and Satodate R. (1994). Int. J. Cancer, 57, 21–25.

  • Montesano R, Hollstein M and Hainaut P. (1996). Int. J. Cancer, 69, 225–235.

  • Wieland I, Arden KC, Michels D, Klein-Hitpass L, Bohm M, Viars CS and Weidle UH. (1999). Oncogene, 18, 4530–4537.

  • Wieland I, Ropke A, Stumm M, Sell C, Weidle UH and Wieacker PF. (2001). Oncol. Res., 12, 491–500.

  • Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C and Micklem G. (1995). Nature, 378, 789–792.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Philip R Taylor.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, WJ., Hu, N., Su, H. et al. Allelic loss on chromosome 13q14 and mutation in deleted in cancer 1 gene in esophageal squamous cell carcinoma. Oncogene 22, 314–318 (2003). https://doi.org/10.1038/sj.onc.1206098

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206098

Keywords

This article is cited by

Search

Quick links